Positive Price Action Smacks Into a Tough Calendar, Few Catalysts
The technical strength is impressive, but it requires a diet of positive news to sustain the momentum.
Today’s SOX Chart Looks a Lot Like It Did in 2024. That May Not Be a Good Thing.
Plus, where on the sentiment cycle is the software sector?
Respect the Rally, Question the Sustainability
We have the biggest weekly gains since April, but a number of negative catalysts are lurking.
If the Equal Weight S&P Is So Strong, Why Isn’t Breadth Rallying?
Let’s dive in and look at the equal-weight S&P and try to understand why breadth isn’t stronger.
I’m Eyeing 2 Biopharma Stocks Amid Choppy Market Action
These small-cap biotechs offer core businesses that fund a much bigger opportunity.
Market Indecision: War Uncertainty, Wacky Econ Data, Fake News?
Investors are stuck dealing with more questions over the state of the Strait, economic data that doesn’t quite make sense, and accusations of fake news.
The Risk of a Bull Trap Is Increasing
The market mood has improved this week, but fundamentals are still under debate.
With Talk of S&P 8000, Here Are Some Sentiment Measures to Watch
With the S&P 500 setting new highs, the bears have left the building. Here’s what I’m paying attention to.
Momentum Fizzles After 2 Big Days, but Here’s What Indexes Didn’t Show
There was still plenty of speculative action in small stocks, but the indexes needed a rest.
Party on Wall St.! Palantir, Micron, SK Hynix Invited! (SpaceX, AMD Not…)
Are ‘Happy Days’ here again? Let’s check the stats, charts and the action on Wall Street. Also, guess who’s getting beat up along the way….